about
Hepatitis C Virus Subtyping by a Core-Envelope 1-Based Reverse Transcriptase PCR Assay with Sequencing and Its Use in Determining Subtype Distribution among Danish Patients[Risk of a new influenza pandemic?].Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.The microbial detection array for detection of emerging viruses in clinical samples--a useful panmicrobial diagnostic tool.Identifying cytotoxic T cell epitopes from genomic and proteomic information: "The human MHC project.".A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice.Amp-PCR: combining a random unbiased Phi29-amplification with a specific real-time PCR, performed in one tube to increase PCR sensitivity.Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.Multicenter quality assessment of PCR methods for detection of enteroviruses.The microbial detection array combined with random Phi29-amplification used as a diagnostic tool for virus detection in clinical samples.Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene.Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach.Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvantCharacteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model.Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120.Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T CellsFirst introduction of highly pathogenic H5N1 avian influenza A viruses in wild and domestic birds in Denmark, Northern Europe.Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus MacaquesHIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).Assessment of HIV-1 patient recruitability in the Republic of Guinea-Bissau using African versus North American hematology and biochemistry reference intervals.The evolution of human influenza A viruses from 1999 to 2006: a complete genome study.Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and DenmarkCharacterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolateRapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.Genetic and biological characterisation of an avian-like H1N2 swine influenza virus generated by reassortment of circulating avian-like H1N1 and H3N2 subtypes in Denmark.Human pegivirus detected in a patient with severe encephalitis using a metagenomic pan-virus array.Full-length characterization of A1/D intersubtype recombinant genomes from a therapy-induced HIV type 1 controller during acute infection and his noncontrolling partner.Therapeutic HIV Peptide Vaccine.HIV-1-infected individuals in antiretroviral therapy react specifically with polyfunctional T-cell responses to Gag p24.Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost.A plasmid selection system in Lactococcus lactis and its use for gene expression in L. lactis and human kidney fibroblasts.[Zika virus epidemic].Inactivation of orthopoxvirus for diagnostic PCR analysis.Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope.Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.
P50
Q27473362-312D259F-319E-4621-9781-F462F6A72E57Q30341034-981220FB-5497-45FF-876F-45759B4A79C7Q30372481-2885D679-8DF8-4F57-BD55-123F6FD3B432Q30388390-51838A98-15AE-4D4E-B988-E1327A7CA2CBQ30397107-8A0CED16-35D8-4C41-B8B1-90DC6E24D8DDQ30428353-6DEE5E6B-0236-48AF-A70D-F6C1DBAFE622Q30833317-C6C53148-BE0F-43AE-9EEE-D8324ADF2476Q31113227-62F7709B-526C-4A2E-97DD-DBD5304B94EBQ33504189-A94212A7-8499-41E0-9BE8-DD0D0B49F125Q33786687-A602CCB4-2A2F-48C3-8BFF-D0E41CEC3E6DQ33955745-D8A1A115-29A9-4E18-B102-A8EF31F9D49FQ33960180-5AEBF9B9-024D-4CD0-9D99-9E72BCF5CEA8Q33996795-EC0AC804-AF80-48AA-9ACB-E38A9FDA6B74Q34002711-327D0129-DFD6-405D-ABBD-299EA76D6E4EQ34276766-760BC39F-1DAA-4C2E-8A49-9B51731C748DQ34532344-B4A029A0-0045-480A-9037-D92AC800BA37Q34730713-2E12A19C-16D7-4BE5-9F4D-7ECBF53A5299Q34793224-39397EC3-873E-4A4A-8D70-D1768D9F3CDDQ34984724-24FB2E61-09D7-4944-82EC-07AF4A95906AQ35623329-7DC1F461-F3E0-4A67-AFA4-1EAC268F156CQ35795271-C2060DA0-5BB5-4B4A-A2F7-A0D88AAC091EQ35809685-2AD5E4C9-97BB-487C-B7D9-8FF30E0437F8Q35826692-E6548211-65B2-4058-9610-FA483CB02FAFQ35876207-DF557B71-027D-446A-AF7F-5AEF1AF17ADCQ36154696-2ADFA0F3-FCEE-4B61-A3F3-FE6A550EA2C2Q36557808-567765BC-C161-4CD7-883E-0E47403D2B2BQ36837324-8D70ABA9-83A5-4984-AC0C-1AFB7CE216E0Q37060319-2E15AAAC-E183-455C-A27A-7971701C0D79Q37280640-2DAA6EF8-318C-4E09-9EB8-07D3FB91959EQ37364961-F4C86984-8DC6-498C-9DA8-687D2C2BEB37Q38731290-0236A7A7-2E64-47BC-93BA-5B9AB9CF9F2DQ38876497-973DDC3F-A71A-41D7-8F29-00359CC900D3Q38958052-4A240256-1788-4660-ACCA-1F35BB02324EQ39449076-EFA79883-1334-45AF-9AB0-F36087013E56Q39562214-F221808B-CFFE-4B9C-AC1F-643E767B6A0DQ39648844-16AAA73A-64E7-43DB-99E1-D1ADBFEC4F16Q40060326-80DED764-D6BC-4DA9-A552-8054527B7A55Q40081923-E63D200A-151F-46BB-896A-D6CC9965216CQ40140237-1F60EA8F-4AF9-42D9-B158-9DD3C517C1CAQ40160424-1E94C5BC-CF86-470A-BBC3-1A6A68A02016
P50
subject
description
researcher, ORCID id # 0000-0003-4304-0603
@en
wetenschapper
@nl
name
Anders Fomsgaard
@ast
Anders Fomsgaard
@en
Anders Fomsgaard
@es
Anders Fomsgaard
@nl
type
label
Anders Fomsgaard
@ast
Anders Fomsgaard
@en
Anders Fomsgaard
@es
Anders Fomsgaard
@nl
prefLabel
Anders Fomsgaard
@ast
Anders Fomsgaard
@en
Anders Fomsgaard
@es
Anders Fomsgaard
@nl
P108
P1006
P214
P1006
P106
P108
P1153
7005971896
P21
P214
P31
P496
0000-0003-4304-0603
P734
P7859
lccn-no2007125351